FDA advisors OK Pfizer COVID booster for seniors, high-risk groups | CIDRAP

Federal vaccine advisors today approved a third booster dose of Pfizer-BioNTech’s COVID-19 vaccine on an emergency use basis, but only for the most vulnerable groups, which includes those age 65 and older and people at high risk of severe disease.

The final vote passed unanimously on an 18 to 0 vote.

Source: FDA advisors OK Pfizer COVID booster for seniors, high-risk groups | CIDRAP